Edition:
United Kingdom

Kaken Pharmaceutical Co Ltd (4521.T)

4521.T on Tokyo Stock Exchange

5,870JPY
23 Jan 2018
Change (% chg)

¥20 (+0.34%)
Prev Close
¥5,850
Open
¥5,850
Day's High
¥5,880
Day's Low
¥5,830
Volume
73,900
Avg. Vol
156,267
52-wk High
¥6,970
52-wk Low
¥5,410

Chart for

About

KAKEN PHARMACEUTICAL CO., LTD. is a Japan-based company engaged in the production and sale of pharmaceutical products. The Company operates in two business segments. The Pharmaceutical segment involves in the manufacture and sale of pharmaceuticals and agricultural drugs. The Real Estate segment is engaged in the leasing of real... (more)

Overall

Beta: 0.05
Market Cap(Mil.): ¥276,106.50
Shares Outstanding(Mil.): 48.44
Dividend: 75.00
Yield (%): 2.63

Financials

  Industry Sector
P/E (TTM): -- 31.11 16.62
EPS (TTM): -- -- --
ROI: -- 14.89 10.61
ROE: -- 16.37 14.21

BRIEF-Kaken Pharmaceutical signs exclusive distribution agreement for Clenafin/Jublia in Taiwan

* Says co signed an exclusive distribution agreement with Tai Tien Pharmaceuticals Co Ltd (Tai Tien), which is a subsidiary of Mitsubishi Tanabe Pharma Corporation, for the topical formulation for Onychomycosis "Clenafin/Jublia" (product) in Taiwan

08 Nov 2017

Earnings vs. Estimates